Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$235,509,177
-$29,776,572 QoQ
Shares Held
1,242,006
-7.7% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#93
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Korea Investment CORP holds $2,440,943,887 across 10 Drug Manufacturers - General names. AZN ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
658,950 | $790,364,464 | |
| 2 | JNJ |
Johnson & Johnson
|
1,849,714 | $469,771,864 | |
| 3 | ABBV |
AbbVie Inc.
|
1,291,102 | $324,892,907 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,861,405 | $239,190,542 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,242,006 | $235,509,177 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,003,135 | $126,736,075 | |
| 7 | AMGN |
Amgen Inc
|
269,926 | $97,745,603 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,501,534 | $86,518,389 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,509,177 | 1,242,006 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $265,285,749 | 1,345,126 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||